Twoother studies with AKI and transplanted patients pointed out that methylationstatus may be a biomarker in AKI patients through the presence ofhypermethylation of kallikrein1 (KLK1) and calcitonin [95, 96]. This evidence concerns the gene KLK1 and acute kidney injury.